Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/19/23
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study to Assess the Safety, Tolerability, PK and PD of ABX1100 | NCT06109948 | Aro Biotherapeutics | user2@example.com | None | 2023-10-19 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |